Related Experiment Video

Updated: Jun 19, 2026

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
08:00

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

[Management of microbial infections in myeloid leukemia]

Fumihiko Monma1, Naoyuki Katayama

  • 1Department of Hematology and Oncology, Mie University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 29, 2009
PubMed

Insights

Patients with acute myeloid leukemia (AML) face high infection risks. Updated Infectious Diseases Society of America (IDSA) guidelines offer recommendations for managing fungal infections in AML patients.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Oncology

Context:

  • Acute myeloid leukemia (AML) patients are highly susceptible to microbial infections.
  • Current management strategies require updates due to evolving treatment landscapes.
  • Infection control evidence in AML is less robust compared to hematopoietic stem cell transplantation.

Purpose:

  • To provide updated recommendations for managing infections in acute myeloid leukemia (AML) patients.
  • To incorporate recent changes in the Infectious Diseases Society of America (IDSA) guidelines, particularly for invasive fungal infections.
  • To highlight areas where further research is needed for effective microbial infection strategies in AML.

Summary:

  • This document outlines current Infectious Diseases Society of America (IDSA) guidelines for managing infections in acute myeloid leukemia (AML) patients.
  • It emphasizes the critical need for appropriate antimicrobial agents and addresses recent advancements in antifungal therapies.
  • The recommendations are based on updated IDSA guidelines, focusing on invasive fungal infections.

Impact:

  • Facilitates evidence-based decision-making for clinicians managing infections in AML patients.
  • Aims to improve patient outcomes by ensuring adherence to the latest infection management protocols.
  • Identifies critical knowledge gaps, stimulating further research into microbial infection control in AML.

More Related Videos

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...